Draxis Health Inc (DAX-T) Stock Predictions - Stockchase
WATCH LIST
4
Draxis Health Inc (DAX-T)

ON STOCKCHASE SINCE Jan 2004

biotechnology/pharmaceutical

Draxis Health Inc

DAX-T

0 watching          
Join the Discussion

Draxis Health Inc (DAX-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about DAX-T



  • All
  • Filtered
Signal Opinion Expert
TOP PICK
Draxis Health Inc(DAX-T) 

March 21, 2007

Good technical pattern. Has been in a congestion area for quite awhile, went through a bit of a correction and has just broke out.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Good technical pattern. Has been in a congestion area for quite awhile, went through a bit of a correction and has just broke out.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Ron Meisels

President, P & C Holdings...

Price Price
$6.960
Owned Owned
Yes

TOP PICK
Draxis Health Inc(DAX-T) 

August 20, 2004

Forecasting 35/40% on manufacturing growth. Earnings are growing substantially from three cents to eight cents. Sales growth of 27%.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Forecasting 35/40% on manufacturing growth. Earnings are growing substantially from three cents to eight cents. Sales growth of 27%.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert McWhirte

President, Selective Asset Mana...

Price Price
$6.000
Owned Owned
Yes

BUY on WEAKNESS
Draxis Health Inc(DAX-T) 

March 2, 2004

Likes what the company is doing. Starting to develop their US relationships. Last quarterly results were excellent. On his watch list.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Likes what the company is doing. Starting to develop their US relationships. Last quarterly results were excellent. On his watch list.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$6.100
Owned Owned
No

TOP PICK
Draxis Health Inc(DAX-T) 

January 30, 2004

Earnings revisions is up 13%. Year-over-year sales are up 29%. Earnings growth is up 107%.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Earnings revisions is up 13%. Year-over-year sales are up 29%. Earnings growth is up 107%.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert McWhirte

President, Selective Asset Mana...

Price Price
$5.500
Owned Owned
Yes

Showing 1 to 4 of 4 entries
Successfully Saved Company
Successfully Saved Company